v3.26.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Level 3 (Tables)
 12 Months Ended
Jul. 31, 2026
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]  
Schedule of Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents and restricted cash as of July 31, 2026, and 2025 reported within the Consolidated Balance Sheets that sum to the total of the same such amounts shown in the Consolidated Statement of Cash Flows (in thousands):

202620252024
Cash and cash equivalents
$73,700 $50,458 $23,481 
Restricted cash included in prepaid expenses and other assets
— — 1,000 
Cash, cash equivalents, and restricted cash
$73,700 $50,458 $24,481 
Inventories
The composition of inventories was as follows as of July 31 (in thousands):
20262025
Finished goods$29,660 $29,401 
Packaging8,605 8,114 
Spare parts6,875 $6,822 
Other8,349 7,257 
Inventories, net
$53,489 $51,594 
Estimated Intangible Amortization Expense
Our estimated intangible amortization expense for the next five fiscal years is as follows (in thousands):
2027$1,199 
2028$1,199 
2029$1,199 
2030$1,199 
2031$1,196 
Acquired Finite-Lived Intangible Assets Weighted Average Amortization Period The remaining weighted average amortization period of our intangibles subject to amortization is as follows (in years):
Weighted Average Amortization Period
Patents7.9
Customer list15.8
Total intangible assets subject to amortization15.5
Schedule of Goodwill
Goodwill by operating segment was as follows as of July 31 (in thousands):
20262025
Business to Business3,618 3,618 
Retail and Wholesale$12,399 12,399 
Total$16,017 $16,017 
Schedule of Earnings Per Share, Basic and Diluted
For the year ended July 31, 2026
(in thousands, except for per share data)
TotalCommonClass B
Net income$56,969 $43,507 $13,462 
Distributed and undistributed earnings on restricted shares(2,400)(1,764)(636)
Income available to stockholders$54,569 $41,743 $12,826 
Net Income (Numerator)$41,743 $12,826 
Weighted Average Shares Outstanding (Denominator)9,876 4,038 
Basic EPS$4.23 $3.18 
Effect of dilution - Net Income (1)
$12,826 $— 
Net income assuming dilution (Numerator)$54,569 $12,826 
Effect of dilution - Shares (1)
4,038 $— 
Shares assuming dilution (Denominator)13,914 $4,038 
Diluted EPS$3.92 $3.18 
(1) The impact of 292,305 shares of unvested Common Stock and 140,150 shares of unvested Class B Stock, restricted stock was anti-dilutive therefore not included in the calculation of diluted EPS for the year ended July 31, 2026.

For the year ended July 31, 2025
(in thousands, except for per share data)
TotalCommonClass B
Net income$53,996 $41,173 $12,823 
Distributed and undistributed earnings on restricted shares(2,580)(1,732)(848)
Income available to stockholders$51,416 $39,441 $11,975 
Net Income (Numerator)$39,441 $11,975 
Weighted Average Shares Outstanding (Denominator)9,889 3,994 
Basic EPS$3.99 $3.00 
Effect of dilution - Net Income (2)
$11,975 $— 
Net income assuming dilution (Numerator)$51,416 $11,975 
Effect of dilution - Shares (2)
3,994 $— 
Shares assuming dilution (Denominator)13,883 $3,994 
Diluted EPS$3.70 $3.00 
(2) The impact of 275,327 shares of unvested Common Stock and 139,484 shares of unvested Class B Stock, restricted stock was anti-dilutive therefore not included in the calculation of diluted EPS for the year ended July 31, 2025.
For the year ended July 31, 2024
(in thousands, except for per share data)
TotalCommonClass B
Net income$39,426 $29,981 $9,445 
Distributed and undistributed earnings on restricted shares(2,165)(1,410)(755)
Income available to stockholders$37,261 $28,571 $8,690 
Net Income (Numerator)$28,571 $8,690 
Weighted Average Shares Outstanding (Denominator)9,771 3,952 
Basic EPS$2.92 $2.20 
Effect of dilution - Net Income (3)
$8,690 $— 
Net income assuming dilution (Numerator)$37,261 $8,690 
Effect of dilution - Shares (3)
3,952 $— 
Shares assuming dilution (Denominator)13,723 $3,952 
Diluted EPS$2.72 $2.20 
(3) The impact of 317,722 shares of unvested Common Stock and 108,740 shares of unvested Class B Stock, restricted stock was anti-dilutive therefore not included in the calculation of diluted EPS for the year ended July 31, 2024.